NEOGEN vs ROSSARI: Stock Comparison

Neogen Chemicals Limited vs Rossari Biotech Limited

Live data: 31 July 2026, 4:08 PM IST • Source: NSE and company filings

Neogen Chemicals Limited is the larger company by market capitalisation. Neogen Chemicals Limited shows faster revenue growth, while Rossari Biotech Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Neogen Chemicals Limited and Rossari Biotech Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, NEOGEN is more favourable on 4 of 13 scored metrics and ROSSARI on 9These counts are context-free and are not an overall rating.

Key Differences

Market Cap
NEOGEN is the larger company
₹5,540 Cr vs ₹2,797 Cr
P/E Ratio
ROSSARI has a lower P/E
18.6x vs 150.45x
P/B Ratio
ROSSARI has a lower P/B
2.1x vs 6.44x
EPS
ROSSARI has higher earnings per share
₹26.91 vs ₹10.93
Dividend Yield
ROSSARI has a higher dividend yield
0.1% vs 0.05%
Revenue Growth (TTM YoY)
NEOGEN has faster revenue growth
21.6% vs 18.2%
EPS Growth (TTM YoY)
NEOGEN has faster EPS growth
375.9% vs 33.5%
Qtr Sales Growth
NEOGEN has stronger quarterly sales growth
21.6% vs 18.2%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNEOGENROSSARI
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricNEOGENROSSARI
Live Price₹2,023.1₹504.3
Day Change1.76%-0.64%
Volume1.75 L37,575
52-Week High₹2,374₹713.1
52-Week Low₹966.7₹375
Distance from 52W High-14.78%-29.28%

Valuation

MetricNEOGENROSSARI
Market Cap₹5,540 Cr₹2,797 Cr
P/E Ratio150.45x18.6x
P/B Ratio6.44x2.1x
EPS₹10.93₹26.91
Book Value₹309.59₹240.75
Dividend Yield0.05%0.1%

Growth

MetricNEOGENROSSARI
Revenue Growth (TTM YoY)21.6%18.2%
EPS Growth (TTM YoY)375.9%33.5%
Qtr Sales Growth21.6%18.2%
Qtr Profit Growth23.7%33.5%

Profitability & Leverage

MetricNEOGENROSSARI
ROE3.58%10.8%
ROCE6.46%13.3%
Net Margin3.33%6.14%
Operating Margin15.9%11.9%
Debt to Equity1.71x0.33x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricNEOGENROSSARI
Promoter Holding49.36% 1.92 pp63.63% 0.01 pp
FII Holding4.11% 0.34 pp2.02% 0.16 pp
DII Holding19.6% 2.88 pp14.64% 3.56 pp
Public Holding23.28% 1.44 pp15.2% 3.74 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Neogen Chemicals Limited and Rossari Biotech Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.